Request Clinical Starter Kits for Your Patients Today! Request Now

 Blood Sugar and Insulin STUDIES

Berberine improves cardiovascular risk factors, meta-analysis shows

Highlights Meta-analysis of 49 clinical trials involving people with CVD Berberine significantly improves obesity, glycemic control, and blood lipid parameters Optimal dosage: 1 g/day (weight loss/blood lipid profile); 1.8 g/day (glycemic...
on April 19, 2024

Berberine for type 2 diabetes: meta-analysis and dosage recommendation

Highlights Meta-analysis of 46 clinical trials involving people with type 2 diabetes Berberine significantly improves glycemic control, blood lipid profile, inflammation, and BMI Typical dosage is 300-500 mg, three times daily,...
on April 03, 2024

Berberine is a potent hypoglycemic agent, comparable to metformin, study shows

Highlights Berberine is as effective as metformin for glycemic control in adults with newly diagnosed type 2 diabetes. Berberine added to usual hypoglycemic therapy improves glycemic control in adults with...
on February 28, 2024

Compared to oral berberine, oral dihydroberberine achieves a higher blood berberine level with lower doses, study shows

Highlights Berberine supplementation has therapeutic value for glycemic control, but digestive upset and poor patient compliance is common. Compared to high-dose berberine (500 mg), low-dose dihydroberberine (100 or 200 mg) significantly (p<.05)...
on January 23, 2024

Tocotrienols as adjunct therapy for chronic diseases, a comprehensive review

Highlights Includes over 3 decades of published research (preclinical & human studies) Research related to common diseases addressed Applications for cardiovascular, cerebrovascular, neurodegenerative diseases & more Summary This comprehensive review...
on February 25, 2020
"